ANR 5.88% 4.8¢ anatara lifesciences ltd

Ann: Investor Presentation on Zoetis exclusive global license, page-16

  1. 227 Posts.
    lightbulb Created with Sketch. 15
    It feels to me like the market is overreacting at the moment. Between the Zoetis deal and Mel Bridges' retirement, the fundamentals or potential of Anatara haven't changed for as far as I can see. Mel still holds close to 6M shares, so I don't think he has lost confidence in the company. After working for 40 years I can understand that he wants to take it easy and let someone else push ANR ahead into the next phase.

    All I can see is a buying opportunity with these prices, but maybe I am missing something....?! I for one have topped up again this morning....
 
watchlist Created with Sketch. Add ANR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.